반응식
Br[C:2]1[CH:7]=[CH:6][C:5]([S:8]([NH:11][C:12]2[CH:17]=[C:16]([N:18]3[CH2:23][C@H:22]([CH3:24])[NH:21][C@H:20]([CH3:25])[CH2:19]3)[CH:15]=[CH:14][C:13]=2[O:26][CH3:27])(=[O:10])=[O:9])=[CH:4][CH:3]=1.[Cl:28][C:29]1[CH:30]=[C:31](B(O)O)[CH:32]=[CH:33][CH:34]=1.CC(C)([O-])C.[K+]>COCCOC.O.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[Cl:28][C:29]1[CH:34]=[C:33]([C:2]2[CH:3]=[CH:4][C:5]([S:8]([NH:11][C:12]3[CH:17]=[C:16]([N:18]4[CH2:19][C@H:20]([CH3:25])[NH:21][C@H:22]([CH3:24])[CH2:23]4)[CH:15]=[CH:14][C:13]=3[O:26][CH3:27])(=[O:10])=[O:9])=[CH:6][CH:7]=2)[CH:32]=[CH:31][CH:30]=1참가 물질
반응물 3
생성물 1
시약·촉매·용매 3
반응 조건
- 온도
- 100 °C
실험 절차
To a mixture of 4-bromo-N-[5-(cis-3,5-dimethyl-1-piperazinyl)-2-(methyloxy)phenyl]benzenesulfonamide (E106) (75 mg, 0.17 mmol) and (3-chlorophenyl)boronic acid (56 mg, 0.36 mmol) in DME (3 ml) was added potassium tert-butoxide (180 mg, 1.60 mmol) and tetrakis(triphenylphosphine)palladium(0) (15 mg, 0.01 mmol) in water (1 ml) and the resulting mixture stirred in a microwave (set at high absorbance) at 100° C. for 30 minutes. The resulting mixture was then evaporated in vacuo and purified using an SCX cartridge eluting with methanol followed by ammonia (2M in methanol). The appropriate fractions were combined and evaporated in vacuo and the residue purified further by mass directed autoprep HPLC to afford the title compound (E111). MS (ES+) m/e 486/488 [M+H]+.
후처리
- customThe resulting mixture was then evaporated in vacuo
- custompurified
- washeluting with methanol
- customevaporated in vacuo
- customthe residue purified further by mass
출처 및 근거
- ORD 기록
- ord-66994927e0a249ea89366cc7dc7e81b2
- 출처 데이터셋
- uspto-grants-2008_06
- 특허 번호
- US07381728B2
연결된 노트
불러오는 중…